CabaƱog, Edna L.
HRN: 26-90-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2025
CEFTRIAXONE 1G (VIAL)
04/03/2025
04/09/2025
IV
2g
OD
Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractMultiple Infections (tick All Sites) Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes